NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Seasonal Affective Disorder: Coping During the Darker Days
Understanding SAD and Its Neurological Impact Seasonal Affective Disorder (SAD) is a type of depression that affects individuals during the [...]
Holiday Stress and Migraines: How to Protect Your Brain Health
The Link Between Holidays and Migraines The holiday season is synonymous with joy, gatherings, and indulgence, but it can also [...]
The Role of TMS Therapy in Treating Seasonal Affective Disorder (SAD)
The Role of TMS Therapy in Treating Seasonal Affective Disorder (SAD) As the days grow shorter and the temperature drops, [...]
How Physical Therapy Supports Neurological Rehabilitation After Stroke
Recovering from a stroke is a complex journey, with each patient needing a personalized path to restore movement, strength, and [...]
Managing Migraine Symptoms Through Lifestyle Changes and Neurological Care
Migraines affect millions of people and can be particularly challenging during seasonal changes and high-stress periods. At Countryside Neurology, we [...]
Understanding EEG Testing for Neurological Diagnoses
For patients experiencing unexplained neurological symptoms, EEG (Electroencephalogram) testing can provide critical information. At Countryside Neurology, EEG tests are part [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social